ABOUT PHARMA INTEGRATES

12-13 November 2018
Grange Tower Bridge Hotel, London

Pharma Integrates is a unique event bringing together key industry leaders across the Pharmaceutical pipeline to share insights and create debate on crucial topics that influence the future of patient outcomes.

Building on a successful 2017, with a presence of more than 90 prestigious speakers and 350 senior industry executives, in 2018 the event moved to a larger venue in Grange Tower Bridge Hotel, London, UK.

The 2018 event included key speaker slots, panel discussions and networking sessions to encourage debate and establish connections between representatives from the entire pharma community, including biotechs, SMEs, small to large pharma companies, CROs, CDMOs, consultants, patient groups and academics.

Topics for discussion ranged from changing pharma’s focus from treatment to prevention, the impact of medtech wearables, developments in cell and gene therapy and surgically removing the industry’s “anticollaboration gene.”

Enquire for 2019

SPEAKERS

Pharma Integrates brings together the top leaders in their field, so they can share insights into the current and future states of the industry.

Sir Andrew Dillon
Chief Executive

National Institute for Health & Care Excellence (NICE)

Erik Nordkamp
UK Managing Director

Pfizer

Nathalie Moll
Director General

EFPIA – European Federation of Pharmaceutical Industries & Associations

Brian Henry
Vice President, Drug Product Design

Pfizer Worldwide Research and Development

Following registration and opening remarks on Monday 12th November, there was an afternoon programme of interviews and plenary panel discussions to which all attendees were invited. The day finished with an early evening networking drinks reception which was open to all.

On Tuesday 13th November there were three tracks of panel discussions and boardroom style workshops running in parallel.

DAY 1 MONDAY 12TH NOVEMBER 2018

INTERVIEWS PLUS PLENARY PANEL DISCUSSIONS

PLEASE CLICK ON THE PLENARY TITLE FOR FULL DESCRIPTION.

Agenda
12:00 – 13:45 Registration And Networking Refreshments
13:45 – 14:05 Welcome and Opening Remarks Presented by Nathalie Moll,
Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA
14:05 – 14:35 Interview with Erik Nordkamp,
UK Managing Director, Pfizer, President, ABPI
14:35 – 15:35 Plenary Panel Discussion: Managing Disruption in Turbulent Times
15:35 – 16:05 Networking Refreshment Break
16:05 – 17:05 Plenary Panel Discussion: Applying New Technologies to the Pharma Value Chain
17:05 – 17:35 Interview with Sir Andrew Dillon,
Chief Executive, National Institute for Health and Care Excellence (NICE)
17:35 – 19:15 Networking Drinks Reception

DAY 1 MONDAY 12TH NOVEMBER 2018

INTERVIEWS PLUS PLENARY PANEL DISCUSSIONS

PLEASE CLICK ON THE PLENARY TITLE FOR FULL DESCRIPTION.

Agenda
12:00 – 13:45
Registration And Networking Refreshments
13:45 – 14:05
Welcome and Opening Remarks
Presented by Nathalie Moll,
Director General, European Federation
of  Pharmaceutical Industries
and Associations (EFPIA)
14:05 – 14:35
Interview with Erik Nordkamp,
UK Managing Director,
Pfizer, President, ABPI
14:35 – 15:35
Plenary Panel Discussion:
Managing Disruption in Turbulent Times
15:35 – 16:05
Networking Refreshment Break
16:05 – 17:05
Plenary Panel Discussion:
Applying New Technologies to
the Pharma Value Chain
17:05 – 17:35
Interview with Sir Andrew Dillon,
Chief Executive,
National Institute for
Health and Care Excellence (NICE)
17:35 – 19:15
Networking Drinks Reception

DAY 2 TUESDAY 13TH NOVEMBER 2018

PANEL DISCUSSIONS

DELEGATES ARE FREE TO CHOOSE FROM TRACK 1,2 or 3 AT ANY TIME. PLEASE CLICK ON THE SESSION TITLE FOR FULL DESCRIPTION.

Enquire for 2019

DAY 2 TUESDAY 13TH NOVEMBER 2018

PANEL DISCUSSIONS

DELEGATES ARE FREE TO CHOOSE FROM TRACK 1,2 or 3 AT ANY TIME. PLEASE CLICK ON THE SESSION TITLE FOR FULL DESCRIPTION.

08:30-08:55 Coffee & Pastries
09:00-10:00
Track 1:
A future course
Challenging Traditional Models:
The New Kids Are on the Block
Track 2:
Making it happen
Outsourcing Everything: The Pros and Cons
Track 3:
The digital voice of the patient

Data, Patient Centricity and Digitalisation
10:05-11:05
Track 1:
A future course
Pre-competitive Partnerships to
Accelerate Drug Development
Track 2:
Making it happen
The Broad-Minded Approach
to CDMO Relationships
Track 3:
The digital voice of the patient
Designing Digital
into Pharma Products
11:05-11:35 Networking Refreshment Break
11:35-12:35
Track 1:
A future course
Strategic Relationships in Pharma
Track 2:
Making it happen
Serialisation: What’s the Strategy Beyond Compliance?
Track 3:
The digital voice of the patient
 Improving the Patient Experience
15:40-16:00 Networking Coffee Break
16:00-17:00
Biotech 2018: On the Crest of a Wave?
Enquire for 2019

EXECUTIVE ADVISORY BOARD

Pharma Integrates is supported by a 25 strong committee of recognised industry experts and leading practitioners

Trevor Jones
Member of the Board & Chairman

eTherapeutics & Simbec Orion Research

Jo Pisani

Jo Pisani
Partner, UK Pharma and Life Sciences Consulting Lead

Strategy&, part of the PwC network

Mark Cassidy

Mark Cassidy
Head of Strategy and Commercial Operations

Ajinomoto Bio-Pharma Services

Cornell Stamoran

Cornell Stamoran
Vice President, Strategy and Corporate Development

Catalent Pharma Solutions

SPONSORS
Discover more sponsors

CONTACT

For all Speaker, Partner, Sponsor & Delegate Enquiries
call Life Science Integrates on +44 (0) 20 8667 9551

Alternatively, please leave your details in this form.